Ningbo Sanxing Medical Electric (601567) Fundamentals 2026 — P/E 22.0x, Revenue Analysis | SniperIQ
Ningbo Sanxing Medical Electric (601567) is a CN-listed Industrials company in Electrical Equipment & Parts with a market capitalization of ¥21.0B, trading at ¥14.94 on the SHH. This SniperIQ fundamentals page covers Ningbo Sanxing Medical Electric's valuation (P/E 22.0x, P/B 1.8x), profitability (net margin 6.8%), revenue (¥14.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Ningbo Sanxing Medical Electric's market cap?
Ningbo Sanxing Medical Electric (601567) has a market capitalization of approximately ¥21.0B, trading at ¥14.94 on the SHH. Market cap moves with the live share price.
What is Ningbo Sanxing Medical Electric's P/E ratio?
Ningbo Sanxing Medical Electric's trailing twelve-month P/E ratio is 22.0x, with a price-to-book (P/B) of 1.8x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Ningbo Sanxing Medical Electric?
Ningbo Sanxing Medical Electric runs a net profit margin of 6.8%, a gross margin of 26.3%, and an operating margin of 6.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Ningbo Sanxing Medical Electric generate?
Ningbo Sanxing Medical Electric reported revenue of ¥14.3B for fiscal year 2025, with net income of ¥1.3B and earnings per share (EPS) of 0.91. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Ningbo Sanxing Medical Electric pay a dividend?
Ningbo Sanxing Medical Electric offers a trailing dividend yield of about 4.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Ningbo Sanxing Medical Electric financially healthy?
Ningbo Sanxing Medical Electric carries a debt-to-equity ratio of 0.54x and a current ratio of 1.89x, with a market beta of 0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Ningbo Sanxing Medical Electric a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ningbo Sanxing Medical Electric (601567) the key facts are: market cap ¥21.0B, P/E 22.0x, revenue ¥14.3B, 52-week range 13.17-33.66. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Ningbo Sanxing Medical Electric's full fundamentals live
Get Ningbo Sanxing Medical Electric's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.